skip to main content

Back to all Representative Matters
Aug 1, 2018

Medipharm Labs Inc. Completes $22.3 Million Private Placement

Melanie Cole, Amy Marcen-Gaudaur, Barbara Worndl and Damian Lu

On June 29, 2018, MediPharm Labs Inc. completed a private placement of 2,070,571 units at a price of $10.778 per Unit for aggregate proceeds of approximately $22,316,600 in connection with its proposed business combination with POCML4 Inc.

Each Unit consists of one class A common share and one half of one share purchase warrant. Each Warrant may be exercised at a price of $15.216 in exchange for one MediPharm class A common share until the date that is 24 months following the closing date of the Transaction.

MediPharm is a licensed Canadian cannabis manufacturer specializing in the pharmaceutical production of oil products. In June 2018, MediPharm commenced the construction of an extraction facility in Australia after completing its application process to extract and import medical cannabis products into Australia.

Aird & Berlis represented MediPharm with a team comprised of Melanie Cole, Daniel Everall and Amy Marcen-Gaudaur (Capital Markets), Barbara Worndl (Tax) and Damian Lu (Summer Student).

Areas of Expertise

Related Industries

Related Representative Matters

Representative Matters
Allied Properties REIT Completes $345 Million Public Equity Offering Margaret T. Nelligan, Sherri M. Altshuler, Anne E. Miatello, Melanie Cole, Liam Tracey-Raymont, Amy Marcen-Gaudaur, Michael D. Smith, Neill Kalvin, Zale Skolnik and Barbara Worndl Jun 24, 2019 Allied Properties Real Estate Investment Trust, a leading owner, manager and developer of distinctive urban workspace in Canada’s major cities and network-dense urban data centres in Toronto that form Canada’s hub for global connectivity, recently completed a $345 million public equity offering o...
Representative Matters
MediPharm Labs Completes $75 Million Bought Deal Financing Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann and Barbara Worndl Jun 18, 2019 MediPharm Labs Corp., a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, recently completed a $75 million bought deal offering of common shares.
Representative Matters
Alexandria Minerals Corporation to be Acquired by O3 Mining Inc. Jeffrey K. Merk, Thomas A. Fenton, Nathan Gates and Francesco Gucciardo May 21, 2019 Alexandria Minerals Corporation has entered into a definitive arrangement agreement with Chantrell Ventures Corp.